BACH1 and cancer: If we can inhibit the degradation of BACH1 in cancer cells upon induction of ferroptosis, the efficacy of anticancer therapies involving ferroptosis, not only cytotoxic drugs but also immune checkpoint therapies (177), will be further enhanced.